| EASL clinical practice guidelines: liver transplantation European Association for The Study of the Liver Journal of hepatology 64 (2), 433-485, 2016 | 1281* | 2016 |
| Liver transplantation in European patients with the hepatitis B surface antigen D Samuel, R Muller, G Alexander, L Fassati, B Ducot, JP Benhamou, ... New England Journal of Medicine 329 (25), 1842-1847, 1993 | 1242 | 1993 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1214 | 2019 |
| Statements from the Taormina expert meeting on occult hepatitis B virus infection G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ... Journal of hepatology 49 (4), 652-657, 2008 | 1171 | 2008 |
| Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) SK Sarin, A Kumar, JA Almeida, YK Chawla, ST Fan, H Garg, HJ de Silva, ... Hepatology international 3, 269-282, 2009 | 1101 | 2009 |
| Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper S Champiat, O Lambotte, E Barreau, R Belkhir, A Berdelou, F Carbonnel, ... Annals of Oncology 27 (4), 559-574, 2016 | 1069 | 2016 |
| Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure R Jalan, F Saliba, M Pavesi, A Amoros, R Moreau, P Ginès, E Levesque, ... Journal of hepatology 61 (5), 1038-1047, 2014 | 1033 | 2014 |
| Early liver transplantation for severe alcoholic hepatitis P Mathurin, C Moreno, D Samuel, J Dumortier, J Salleron, F Durand, ... New England Journal of Medicine 365 (19), 1790-1800, 2011 | 1024 | 2011 |
| Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma … V Vilgrain, H Pereira, E Assenat, B Guiu, AD Ilonca, GP Pageaux, A Sibert, ... The Lancet Oncology 18 (12), 1624-1636, 2017 | 855 | 2017 |
| Systemic inflammation in decompensated cirrhosis: characterization and role in acute‐on‐chronic liver failure J Clària, RE Stauber, MJ Coenraad, R Moreau, R Jalan, M Pavesi, ... Hepatology 64 (4), 1249-1264, 2016 | 789 | 2016 |
| Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 SK Sarin, CK Kedarisetty, Z Abbas, D Amarapurkar, C Bihari, AC Chan, ... Hepatology international 8, 453-471, 2014 | 747 | 2014 |
| Clinical course of acute‐on‐chronic liver failure syndrome and effects on prognosis T Gustot, J Fernandez, E Garcia, F Morando, P Caraceni, C Alessandria, ... Hepatology 62 (1), 243-252, 2015 | 725 | 2015 |
| Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection European FK506 Multicentre Liver Study Group The Lancet 344 (8920), 423-428, 1994 | 683 | 1994 |
| Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study R Moreau, F Durand, T Poynard, C Duhamel, JP Cervoni, P Ichaï, ... Gastroenterology 122 (4), 923-930, 2002 | 637 | 2002 |
| EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure J Wendon, J Cordoba, A Dhawan, FS Larsen, M Manns, F Nevens, ... Journal of hepatology 66 (5), 1047-1081, 2017 | 618 | 2017 |
| Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study F Carrat, H Fontaine, C Dorival, M Simony, C Hezode, V De Ledinghen, ... The Lancet 393 (10179), 1453-1464, 2019 | 600 | 2019 |
| Adefovir Dipivoxil Therapy for Lamivudine–Resistant Hepatitis B in Pre-and Post-Liver Transplantation Patients ER Schiff, CL Lai, S Hadziyannis, P Neuhaus, N Terrault, M Colombo, ... Hepatology 38 (6), 1419-1427, 2003 | 582 | 2003 |
| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version) TE Jury Journal of Hepatology 39, 3-25, 2003 | 575 | 2003 |
| Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)–NCT01514890 C Hézode, H Fontaine, C Dorival, D Larrey, F Zoulim, V Canva, ... Journal of hepatology 59 (3), 434-441, 2013 | 560 | 2013 |
| Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 … M Manns, D Samuel, EJ Gane, D Mutimer, G McCaughan, M Buti, ... The Lancet Infectious Diseases 16 (6), 685-697, 2016 | 525 | 2016 |
